Table 2 Demographic and behavioural information of the study participants in the final analysis for gradual onset ME/CFS (GO-ME/CFS) group.
Characteristics | GO-ME/CFS participants (n = 33) | Healthy controls (HCs, n = 33) | p values |
|---|---|---|---|
Female/male | 26/7 | 26/7 | n/a |
Age (years) | 42.03 ± 12.87 [24, 62] | 42.18 ± 7.35 [21, 58] | 0.75 |
BMI (kg/m2) | 24.98 ± 4.75 [18.69, 34.89] | 26.10 ± 4.01 [20.20, 33.87] | 0.27 |
MET rate | 1.30 ± 0.15 [1.04, 1.72] | 1.36 ± 0.15 [1, 1.61] | 0.09 |
MRI scan time | 11.77 ± 1.78 [7.80, 15.88] | 11.68 ± 1.63 [9.08, 16.10] | 0.57 |
HADS-anxiety | 8.97 ± 5.21 [1, 18] | 4.42 ± 2.97 [0, 14] | < 0.001 |
HADS-depression | 7.21 ± 4.41 [1, 17] | 2.06 ± 2.73 [0, 11] | < 0.001 |
SF-36 - MCS | 42.95 ± 9.03 [23.34, 56.77] | 52.78 ± 6.13 [38.57, 60.36] | < 0.001 |
SF-36 - PCS | 37.56 ± 6.49 [27.10, 50.68] | 58.45 ± 7.95 [35.43, 68.30] | < 0.001 |
Global PSQI | 9.09 ± 3.39 [3, 15] | 4.48 ± 3.21 [1, 13] | < 0.001 |
BDS | 43.94 ± 14.35 [10, 70] | 94.55 ± 12.77 [50, 100] | < 0.001 |
Disease severity | 2.76 ± 1.06 [1, 4] | n/a | n/a |
Disease duration (years) | 10.27 ± 7.52 [1.5, 28] | n/a | n/a |